S100B and AIDS: We expressed HIV-1 Nef because it has gained increased interest as a new therapeutic target for HIV/AIDS treatment in recent years [14, 15, 16, 17, 18, 19] and we are engineering cell internalizing antibodies to target this pathogenic factor.